The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for JP Jones


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.EBI
Pfizer
Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase.EBI
Washington State University
Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4.EBI
Washington State University
CNAD: a potent and specific inhibitor of alcohol dehydrogenase.EBI
University of Rochester Medical Center
Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.EBI
Washington State University
Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.EBI
Washington State University
High confidence predictions of drug-drug interactions: predicting affinities for cytochrome P450 2C9 with multiple computational methods.EBI
Washington State University
Charge and substituent effects on affinity and metabolism of benzbromarone-based CYP2C19 inhibitors.EBI
Washington State University
A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions.EBI
Washington State University